The Heart of Innovation - Dr. Manessis on New Diabetes Innovation
Podcasts > The Heart of Innovation
Saturday, March 28, 2026
Is everything you know about obesity and diabetes wrong? Join Emmy Award-winning journalist Kym McNicholas and interventional cardiologist Dr. John Phillips on The Heart of Innovation as they sit down with world-renowned endocrinologist Dr. Anastasios Manessis. In this episode, we dive deep into the rapidly accelerating world of metabolic health to separate fact from fiction.
What We Cover:
-
GLP-1 Breakthroughs: We go beyond the headlines to discuss the real-world impact of GLP-1 and GIP receptor agonists in managing chronic disease and cardiovascular health.
-
The New Bag Gastric Balloon: Kym and Dr. Phillips explore the latest non-surgical innovations, including the recently FDA-cleared Allurion Gastric Balloon System. This swallowable technology—often referred to as a pill-sized bag—occupies gastric volume to support weight management without the need for surgery, endoscopy, or anesthesia.
-
Myth-Busting Obesity Care: Dr. Manessis addresses common misconceptions about weight loss medications and the shifting clinical standards for 2026.
-
A Holistic Approach: Learn how endocrinology-driven strategies combine nutrition, exercise, and medicine for long-term health optimization.
About Our Guest:
Dr. Anastasios Manessis, MD, FACE, ECNU, ABOM, is a double board-certified endocrinologist specializing in diabetes, metabolism, and obesity medicine. As the lead at Endocrine Associates of West Village PC, he is at the forefront of innovative, patient-focused metabolic care.
Don't miss this essential guide to the new hope—and new meds—changing lives in 2026.
Subscribe to our channel for more life-saving breakthroughs!
SHAREABLE LINK TO WATCH: https://youtube.com/live/dAJZsb8WQJ0?feature=share
#ObesityTreatment #DiabetesCare #GLP1 #WeightLossInnovation #GastricBalloon #HeartOfInnovation #MedicalAdvances #DrAnastasiosManessis #KymMcNicholas #DrJohnPhillips
Related Episodes
Golf, fitness, diabetes reversal: Vern Glenn Explains
Saturday, March 28
A CEO's Life Long Battle With Apical Hypertrophic Cardiomyopathy
Saturday, March 28
